Novel Papain-Like Protease Inhibitors for Treating Viral Infections, in particular, Coronavirus Infections.

Provided herein are novel papain-like protease (PLpro) inhibitors, pharmaceutical compositions, use of such compounds in treating viral infections, in particular, coronavirus infections, and processes for preparing such compounds.